1d
Zacks Investment Research on MSNBoston Scientific (BSX) Exceeds Market Returns: Some Facts to ConsiderBoston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other hand, ...
Boston Scientific disclosed executive pay for 2024 and reported a rebound in its median employee's pay after a large drop the ...
Michael Mahoney, longtime CEO of the Marlborough medical device company, saw his total compensation package hit $21.4 million ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery. An ambitious start-up embodies new optimism that artificial intelligence can ...
(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.
MARLBOROUGH, Mass., Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V ...
TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration. The ...
TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration.
The FDA is further elevating a pacemaker recall from Boston Scientific that it first broadcast in December over certain Accolade implants that can place themselves into a permanent safety mode and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results